HemaSphere
(Jun 2022)
P471: ERYTHROID/MEGAKARYOCYTIC DIFFERENTIATION BIAS IN BONE MARROW OF AML/MDS PATIENTS AFTER DECITABINE TREATMENT
- F. Tiso,
- A. O. de Graaf,
- L. I. Kroeze,
- B. A. van der Reijden,
- S. M. C. Langemeijer,
- K. M. Hebeda,
- J. H. Jansen
Affiliations
- F. Tiso
- 1 Department of Laboratory Medicine, Laboratory of Hematology
- A. O. de Graaf
- 1 Department of Laboratory Medicine, Laboratory of Hematology
- L. I. Kroeze
- 2 Department of Pathology
- B. A. van der Reijden
- 1 Department of Laboratory Medicine, Laboratory of Hematology
- S. M. C. Langemeijer
- 3 Department of Hematology, Radboudumc, Nijmegen, Netherlands
- K. M. Hebeda
- 2 Department of Pathology
- J. H. Jansen
- 1 Department of Laboratory Medicine, Laboratory of Hematology
- DOI
-
https://doi.org/10.1097/01.HS9.0000844772.42117.cb
- Journal volume & issue
-
Vol. 6
pp.
370
– 371
WeChat QR code